Hari Reddy Mallidi

Hari Reddy Mallidi

Auto-generated profile, based on publicly available information

Hari Reddy Mallidi

Division of Cardiothoracic Transplantation and Mechanical Circulatory Support, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florida

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in New England Journal of Medicine
Verified
Journal Article
Closed access
JSJacob N. Schroder
Jacob N. Schroder
CPChetan B. Patel
Chetan B. Patel
ADAdam D. DeVore
Adam D. DeVore
BBBenjamin S. Bryner
Benjamin S. Bryner
SCSarah Casalinova
Sarah Casalinova
DDDavid A. D’aLessandro
David A. D’aLessandro
Data showing the efficacy and safety of the transplantation of hearts obtained from donors after circulatory death as compared with hearts obtained from donors after brain death are limited. We conducted a randomized, noninferiority trial in which adult candidates for heart transplantation were assigned in a 3:1 ratio to receive a heart after the circulatory death of the donor or a heart from a donor after brain death if that heart was available first (circulatory-death group) or to receive only a heart that had been preserved with the use of traditional cold storage after the brain death of the donor (brain-death group). The primary end point was the risk-adjusted survival at 6 months in the as-treated circulatory-death group as compared with the brain-death group. The primary safety end point was serious adverse events associated with the heart graft at 30 days after transplantation. A total of 180 patients underwent transplantation; 90 (assigned to the circulatory-death group) received a heart donated after circulatory death and 90 (regardless of group assignment) received a heart donated after brain death. A total of 166 transplant recipients were included in the as-treated primary analysis (80 who received a heart from a circulatory-death donor and 86 who received a heart from a brain-death donor). The risk-adjusted 6-month survival in the as-treated population was 94% (95% confidence interval [CI], 88 to 99) among recipients of a heart from a circulatory-death donor, as compared with 90% (95% CI, 84 to 97) among recipients of a heart from a brain-death donor (least-squares mean difference, -3 percentage points; 90% CI, -10 to 3; P<0.001 for noninferiority [margin, 20 percentage points]). There were no substantial between-group differences in the mean per-patient number of serious adverse events associated with the heart graft at 30 days after transplantation. In this trial, risk-adjusted survival at 6 months after transplantation with a donor heart that had been reanimated and assessed with the use of extracorporeal nonischemic perfusion after circulatory death was not inferior to that after standard-care transplantation with a donor heart that had been preserved with the use of cold storage after brain death. (Funded by TransMedics; ClinicalTrials.gov number, NCT03831048.).

28 August 2015 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ABAndrew C. W. Baldwin
Andrew C. W. Baldwin
HMHari R. Mallidi
Hari R. Mallidi
JBJohn C. Baldwin
John C. Baldwin
ESElena Sandoval
Elena Sandoval
WCWilliam E. Cohn
William E. Cohn
SSSteve K. Singh
Steve K. Singh

1 January 2022 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
FYFarhang Yazdchi
Farhang Yazdchi
SHSameer A Hirji
Sameer A Hirji
MHMorgan Harloff
Morgan Harloff
SMSiobhan McGurk
Siobhan McGurk
KMKaren Morth
Karen Morth
SASary Aranki
Sary Aranki

1 April 2014 in Texas Heart Institute Journal
Verified
Journal Article
Open access
HMHari R. Mallidi
Hari R. Mallidi
JAJatin Anand
Jatin Anand
WCWilliam E. Cohn
William E. Cohn
Mechanical circulatory support of the failing heart has become an important means of treating end-stage heart disease. This rapidly growing therapeutic field has produced impressive clinical outcomes and has great potential to help thousands of otherwise terminal patients worldwide. In this review, we examine the state of the art of mechanical circulatory support: current practice, totally implantable systems of the future, evolving biventricular support mechanisms, the potential for myocardial recovery and adjunctive treatment methods, and miniaturized devices with expanded indications for therapy.

1 April 2022 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
SHSameer A Hirji
Sameer A Hirji
RSRohan Shah
Rohan Shah
SASary Aranki
Sary Aranki
SMSiobhan McGurk
Siobhan McGurk
SSSteve Singh
Steve Singh
TKTsuyoshi Kaneko
Tsuyoshi Kaneko

5 October 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
PDF file
MBMudassir M Banday
Mudassir M Banday
SRSangeetha B Rao
Sangeetha B Rao
SSShruthi Shankar
Shruthi Shankar
MKMudasir A. Khanday
Mudasir A. Khanday
JFJon Finan
Jon Finan
NSNirmal Sharma
Nirmal Sharma